Dana Investment Advisors Inc. Trims Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Dana Investment Advisors Inc. decreased its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 7.9% during the third quarter, HoldingsChannel.com reports. The firm owned 15,409 shares of the biotechnology company’s stock after selling 1,315 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Rocket Pharmaceuticals were worth $316,000 at the end of […]

Related Keywords

Gaurav Shah ,Martin Wilson ,Rathbones Group ,Nasdaq ,Securities Exchange Commission ,Rocket Pharmaceuticals ,Cantor Fitzgerald ,Bamco Inc ,Financial Services Group Inc ,Rocket Pharmaceuticals Inc ,Rocket Pharmaceuticals Profile ,Dana Investment Advisors Inc ,Rocket Pharmaceuticals Stock Performance ,York Mellon Corp ,Needham Company ,News Ratings For Rocket Pharmaceuticals Daily ,Charles Schwab Investment Management Inc ,Quarter For Rocket Pharmaceuticals ,Jpmorgan Chase Co ,Dana Investment Advisors ,Free Report ,Investment Advisors ,Schwab Investment Management ,New York Mellon Corp ,Services Group ,Get Free Report ,Exchange Commission ,General Counsel Martin Wilson ,Visit Holdingschannel ,Rocket Pharmaceuticals Daily ,